CZD Share Price

Open 0.10 Change Price %
High 0.10 1 Day 0.00 0.00
Low 0.09 1 Week 0.00 0.00
Close 0.09 1 Month 0.00 0.00
Volume 296898 1 Year 0.00 0.00
52 Week High 0.10
52 Week Low 0.03
CZD Important Levels
Resistance 2 0.10
Resistance 1 0.10
Pivot 0.09
Support 1 0.08
Support 2 0.08
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
GPP 0.03 0.00%
PDN 0.06 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GMR 0.01 0.00%
GMR 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
BMN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
HOG 0.00 -100.00%
HOG 0.00 -100.00%
PCL 0.00 -100.00%
PCL 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GTG 0.01 -50.00%
More..

Calzada Ltd (ASX: CZD)

CZD Technical Analysis 3
As on 28th Nov 2014 CZD Share Price closed @ 0.09 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.10 & Sell for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
CZD Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
CZD Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.metabolic.com.au
CZD Address
CZD
2/320 Lorimer Street
Port Melbourne, VIC 3207
Australia
Phone: 61 3 8681 4050
Fax: 61 3 8681 4099
CZD Latest News
Interactive Technical Analysis Chart Calzada Ltd ( CZD ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Calzada Ltd
CZD Business Profile
Calzada Limited, through its subsidiaries, focuses on developing medical devices for reconstructive surgery and tissue repair incorporating its patented biodegradable polymer technology NovoSorb. Its NovoPore dressing is used for topical negative pressure therapy in the treatment of chronic wounds, such as pressure sores. The company is also developing dermal replacement wound treatment device using the NovoSorb biodegradable temporizing matrix. In addition, it owns AOD9604, a 16 amino acid peptide based on a fragment of the C-terminus end of human growth hormone, which has applications in the treatment of obesity, bone, cartilage, and muscle diseases and repair. Calzada Limited is based in Port Melbourne, Australia.